Moreover, macrophage was the main resource of TNF-α in diseased lung, and we elucidated that FZHY could inhibit pro-inflammatory macrophage activation via NF-κB/TNF-α signaling pathway, which was closely associated with its efficacy on lung fibrosis. The gene discussed is NFKB1; the disease is pulmonary fibrosis.